Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
SVP & Chief Technology Officer
embecta
Colleen Riley serves as the SVP, Chief Technology Officer for embecta. Previously, Colleen was the Senior Vice President of Innovation and Development for Terumo Blood and Cell Technologies. Under Colleen’s leadership, she advanced existing and new product platforms beyond the traditional scope of medical devices and therapy manufacturing to include services, software, and data management. Prior to that role, she served as Vice President of Science and Technology and Vice President of Regulatory Affairs and Compliance at Stryker Orthopedics. During this tenure, she led a regulatory transformation that delivered pivotal Mako robotic clearances and expanded 3D printing capabilities. These initiatives led to optimized orthopedic implant design, improved functional outcomes and patient satisfaction, and drove market-leading growth. A Doctor of Optometry, Colleen started her professional career in private practice before joining the Indiana University School of Optometry as Clinical Faculty, Residency Program Supervisor, and Co-Director of the Clinic. Colleen earned a Bachelor of Arts in Chemistry, a Master of Science in Physiological Optics, and an OD, Doctor of Optometry, degree from Indiana University.
